T h e ne w e ngl a nd jou r na l o f m e dic i ne c o r r e s p o n d e n c e
Prevention of Surgical-Site Infections
To the Editor: I am concerned about the generalizability of the findings of Bode et al. (Jan. 7 issue) 1 regarding the identification of nasal carriers of Staphylococcus aureus and the subsequent use of mupirocin nasal ointment and chlorhexidine soap. First, it is unclear how the researchers identified patients who were expected to be hospitalized for 4 or more days, since no specific protocol is provided. Second, key surgical data are lacking, despite the preponderance of surgical patients (88%). No data are provided on the appropriateness of antimicrobial prophylaxis, in particular the timing of administration; 84 of 828 surgical patients (10%) received no prophylaxis. Similarly, no data are provided to explain the high rate of infection: among surgical patients, S. aureus infection developed in 3.6% of those receiving prophylaxis and 8.4% of those receiving placebo; 11 to 12% of patients had non-S. aureus infection. Would the intervention be as effective in a hospital with lower baseline rates of infection? Finally, it is unclear whether such a screening protocol would work in settings with a high rate of methicillin-resistant S. aureus infection, as is the case in many community hospitals. Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS.
2.
Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicil- [1] [2] [3] [4] In 980 isolates of methicillin-resistant S. aureus, we found that an increase in the monthly use of mupirocin had a significant association with subsequent increases in low-level resistance after 1 month (P = 0.05) and in highlevel resistance after 2 months (P = 0.03). Mupirothis week's letters cin resistance in methicillin-susceptible S. aureus was uncommon during the 4.5-year period (9 cases of resistance in 342 isolates), and the use of mupirocin was not correlated with lagged resistance in the subsequent 12 months. These data suggest an ecologic association between mupirocin use and resistance in methicillin-resistant S. aureus. These findings have implications for facilities instituting decolonization programs, since the increased use of mupirocin may reduce the drug's effectiveness. Kerry L. LaPlante, Pharm.D.
